Major Shareholder Announcement
Genmab A/S disclosed that Darwin Global Management Limited controls voting rights attached to 3,188,361 shares, or 5.11% of Genmab's voting rights, as of September 28, 2026. The notice is a routine filing under Section 30 of the Danish Capital Markets Act, triggered by Darwin crossing the 5% threshold through funds it manages via shares and ADRs.
Key figures
- Shares controlled
- 3188361
- Voting rights pct
- 5.11%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.